157 related articles for article (PubMed ID: 31670839)
1. Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A-mediated drug hepatotoxicity.
Liu J; Jin X; Zhou F; Chen H; Wang W; Liu Y; Wang G; Hao K; Zhang J
Br J Pharmacol; 2020 Apr; 177(7):1538-1555. PubMed ID: 31670839
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the pentose phosphate pathway alters phase I metabolism of testosterone and dextromethorphan in HepG2 cells.
Xiao WJ; Ma T; Ge C; Xia WJ; Mao Y; Sun RB; Yu XY; Aa JY; Wang GJ
Acta Pharmacol Sin; 2015 Feb; 36(2):259-67. PubMed ID: 25619394
[TBL] [Abstract][Full Text] [Related]
3. Impaired pentose phosphate pathway in the development of 3D MCF-7 cells mediated intracellular redox disturbance and multi-cellular resistance without drug induction.
Wang W; Cai Q; Zhou F; Liu J; Jin X; Ni P; Lu M; Wang G; Zhang J
Redox Biol; 2018 May; 15():253-265. PubMed ID: 29291545
[TBL] [Abstract][Full Text] [Related]
4. Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity.
Kostrubsky VE; Szakacs JG; Jeffery EH; Wood SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
Toxicol Appl Pharmacol; 1997 Apr; 143(2):315-23. PubMed ID: 9144448
[TBL] [Abstract][Full Text] [Related]
5. Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes.
Shen G; Zhuang X; Xiao W; Kong L; Tan Y; Li H
Food Chem Toxicol; 2014 Sep; 71():90-6. PubMed ID: 24910460
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive assessment of Cucurbitacin E related hepatotoxicity and drug-drug interactions involving CYP3A and P-glycoprotein.
Lu J; Zhang Y; Sun M; Liu M; Wang X
Phytomedicine; 2017 Mar; 26():1-10. PubMed ID: 28257659
[TBL] [Abstract][Full Text] [Related]
7. Role of CYP3A and CYP2E1 in alcohol-mediated increases in acetaminophen hepatotoxicity: comparison of wild-type and Cyp2e1(-/-) mice.
Wolf KK; Wood SG; Allard JL; Hunt JA; Gorman N; Walton-Strong BW; Szakacs JG; Duan SX; Hao Q; Court MH; von Moltke LL; Greenblatt DJ; Kostrubsky V; Jeffery EH; Wrighton SA; Gonzalez FJ; Sinclair PR; Sinclair JF
Drug Metab Dispos; 2007 Jul; 35(7):1223-31. PubMed ID: 17392391
[TBL] [Abstract][Full Text] [Related]
8. Reversing effects of silybin on TAA-induced hepatic CYP3A dysfunction through PXR regulation.
Xie Y; Hao HP; Wang H; Wang ZX; Wang GJ
Chin J Nat Med; 2013 Nov; 11(6):645-52. PubMed ID: 24345506
[TBL] [Abstract][Full Text] [Related]
9. The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1.
Shu N; Hu M; Ling Z; Liu P; Wang F; Xu P; Zhong Z; Sun B; Zhang M; Li F; Xie Q; Liu X; Liu L
Sci Rep; 2016 Sep; 6():33072. PubMed ID: 27624558
[TBL] [Abstract][Full Text] [Related]
10. Dictamnine-induced hepatotoxicity in mice: the role of metabolic activation of furan.
Shi F; Pan H; Cui B; Li Y; Huang L; Lu Y
Toxicol Appl Pharmacol; 2019 Feb; 364():68-76. PubMed ID: 30578885
[TBL] [Abstract][Full Text] [Related]
11. Extra-hepatic cancer represses hepatic drug metabolism via interleukin (IL)-6 signalling.
Kacevska M; Mahns A; Sharma R; Clarke SJ; Robertson GR; Liddle C
Pharm Res; 2013 Sep; 30(9):2270-8. PubMed ID: 23604979
[TBL] [Abstract][Full Text] [Related]
12. ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.
Yin X; Tang B; Li JH; Wang Y; Zhang L; Xie XY; Zhang BH; Qiu SJ; Wu WZ; Ren ZG
J Exp Clin Cancer Res; 2017 Nov; 36(1):166. PubMed ID: 29169374
[TBL] [Abstract][Full Text] [Related]
13. RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity.
Walubo A; Barr S; Abraham AM
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):423-31. PubMed ID: 17003847
[TBL] [Abstract][Full Text] [Related]
14. Alcohol-mediated increases in acetaminophen hepatotoxicity: role of CYP2E and CYP3A.
Sinclair J; Jeffery E; Wrighton S; Kostrubsky V; Szakacs J; Wood S; Sinclair P
Biochem Pharmacol; 1998 May; 55(10):1557-65. PubMed ID: 9633991
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of luteolin in primary rat hepatocytes: the role of CYP3A-mediated ortho-benzoquinone metabolite formation and glutathione depletion.
Shi F; Zhao P; Li X; Pan H; Ma S; Ding L
J Appl Toxicol; 2015 Nov; 35(11):1372-80. PubMed ID: 25612170
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-induced inhibition of adipogenesis was p53-dependent and associated with inactivation of pentose phosphate pathway.
Su YF; Yang SH; Lee YH; Wu BC; Huang SC; Liu CM; Chen SL; Pan YF; Chou SS; Chou MY; Yang HW
Eur J Pharmacol; 2014 Sep; 738():101-10. PubMed ID: 24726874
[TBL] [Abstract][Full Text] [Related]
17. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.
Jiang LL; Jiang Y; Zhao DS; Fan YX; Yu Q; Li P; Li HJ
Chem Res Toxicol; 2018 Oct; 31(10):1052-1060. PubMed ID: 30203651
[TBL] [Abstract][Full Text] [Related]
18. Estimating pentose phosphate pathway activity from the analysis of hepatic glycogen
Belew GD; Di Nunzio G; Tavares L; Silva JG; Torres AN; Jones JG
Magn Reson Med; 2020 Nov; 84(5):2765-2771. PubMed ID: 32301167
[TBL] [Abstract][Full Text] [Related]
19. A possible role of microglia-derived nitric oxide by lipopolysaccharide in activation of astroglial pentose-phosphate pathway via the Keap1/Nrf2 system.
Iizumi T; Takahashi S; Mashima K; Minami K; Izawa Y; Abe T; Hishiki T; Suematsu M; Kajimura M; Suzuki N
J Neuroinflammation; 2016 May; 13(1):99. PubMed ID: 27143001
[TBL] [Abstract][Full Text] [Related]
20. Upgrading cytochrome P450 activity in HepG2 cells co-transfected with adenoviral vectors for drug hepatotoxicity assessment.
Tolosa L; Donato MT; Pérez-Cataldo G; Castell JV; Gómez-Lechón MJ
Toxicol In Vitro; 2012 Dec; 26(8):1272-7. PubMed ID: 22138474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
